IBRX Operating Cash Flow (Statement)
Immunitybio Inc · Operating Cash Flow (Statement)
IBRX Operating Cash Flow (Statement)
Latest reported-$281.14Mperiod ending
IBRX Cash from Operations (-$668.00K → -$281.14M)
Annual operating cash flow (statement)
High-resolution chart · PNG
IBRX operating cash flow (statement) history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | Operating Cash Flow (Statement) (USD) |
|---|---|
| -304,936,000 | |
| -391,236,000 | |
| -366,757,000 | |
| -337,509,000 | |
| -274,419,000 | |
| -171,724,000 | |
| -152,109,000 | |
| -63,381,000 | |
| -48,780,000 | |
| -38,593,000 | |
| -25,305,000 | |
| -5,354,000 | |
| -668,000 |